Mpox virus transmissible from mother to child during pregnancy


The new variant of the mpox virus, which spreads through skin and sexual contact, can also be transmitted from mother to unborn child via the placenta. This has been revealed by research conducted by the Congolese National Institute for Biomedical Research (INRB) and ITM. The transmission can lead to serious pregnancy complications, including miscarriage and stillbirth.
In the study, the scientists examined three pregnant women, each in a different trimester of their pregnancy, who became infected with the Clade Ib variant of the mpox virus during the recent outbreak in the Democratic Republic of Congo (DRC). "In all three women, the virus infected the foetus via the placenta," says Professor Laurens Liesenborghs, an expert in emerging infectious diseases at ITM. "The infection led to a miscarriage, a stillbirth and, in one case, a newborn with mpox. We found lesions on the face and body of both the foetus and the child."
Mpox had previously been linked to pregnancy complications, but evidence of mother-to-child transmission had been limited until now. This study adds mpox to the list of viruses that can affect the foetus, such as the rubella virus (which causes rubella), the varicella virus (which causes chickenpox) and the Zika virus.
This has important consequences, because in the current outbreak of the Clade Ib variant in the DRC, which is mainly spread through sexual contact, young women are very often infected. This increases the number of infections among pregnant women.
Professor Placide Mbala-Kingebeni, head of the Epidemiology and Global Health Department at INRB, emphasises the urgency: "Every day, women are at risk of infection. We must take urgent action to better protect them and, in the event of pregnancy, their unborn children. It is also crucial to contain the outbreak in large parts of the DRC, including Kinshasa. Vaccination and safe, effective treatments are urgently needed."
Funding
The study was funded by the Belgian Directorate-General for Development Cooperation and Humanitarian Aid, the European & Developing Countries Clinical Trials Partnership (EDCTP3) and the Research Foundation - Flanders (FWO).
ITM and INRB have been collaborating on mpox research for many years. With support from the Belgian Directorate-General for Development Cooperation and Humanitarian Aid, they were able to identify the new virus variant, a breakthrough that contributed to the declaration of an international health crisis. This gave impetus to large-scale vaccination campaigns in the DRC. Belgium is supporting the INRB and ITM in administering vaccines to 10,000 vulnerable patients, while also investigating how effective the vaccines are in people with multiple co-morbidities.
Full article
The study was published in The New England Journal of Medicine.

MBOTE-SK
The overall objective of the MBOTE-SK project is to provide the first comprehensive clinical, epidemiological, and genomic research describing the Clade Ib MPXV outbreak and to use it to inform an effective response.
Spread the word! Share this story on